Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on COUNTRYWIDE PLC. We currently have 4 research reports from 2 professional analysts.
|16Mar17 10:00||RNS||Holding(s) in Company|
|15Mar17 17:30||RNS||Holding(s) in Company|
|14Mar17 16:35||RNS||Holding(s) in Company|
|13Mar17 15:40||RNS||Total Voting Rights|
|13Mar17 12:00||RNS||Holding(s) in Company|
|09Mar17 14:52||RNS||Director/PDMR Shareholding|
|09Mar17 10:44||RNS||Results of Placing|
Frequency of research reports
Research reports on
Chill for agents, spring in housing volumes
24 Nov 16
Yesterday’s Autumn Statement appears to be: good for 'alternative' housing providers, UK-focused contractors and materials producers; potentially problematic for mainstream housebuilders; and bad news especially for lettings-dominated agents. Chancellor Philip Hammond’s key spending measures included an additional £3.7bn funding to boost new housing volumes and £1.1bn for roads. Shares in estate agents, however, have fallen in response to the threat to ban them from charging fees to tenants.
Panmure Morning Note 31-07-15
31 Jul 15
We have made further cuts to earnings and dividend estimates partly on the back of the disappointing interim figures and also to reflect higher costs and depreciation charges given the ambitious plans announced to double the business over the period to 2020. While the shares have sold off 4%, lower earnings estimates leaves them trading on a full PE of 14x for the current year. We remain on a hold with a 570 target.
Panmure Morning Note 30-07-15
30 Jul 15
First half PBT of £28.9m was below expectations. Transaction volumes fell by 12% as H1 was adversely affected by the election. The outlook for the housing looks better for the second half though affordability is an increasing issue. We have already taken our FY15 forecasts down in anticipation. The current year PE is 13.8x. We are retaining our hold recommendation and 570p target.
Panmure Morning Note 16-07-15
16 Jul 15
Assuming lower interim profits owing to the election impact, we have cut our forecasts for FY15 by 7% bringing them close to consensus. If there is a strong enough rebound in the second half this may be conservative. The shares are down 10% in the last month and trade on 11.9x FY16 revised earnings. We retain our Hold recommendation and 570p price target given the favourable longer term outlook for the housing market.
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
N+1 Singer - N1S Trend spotting - Strategy update
08 Mar 17
In this new product we present some strategy theme updates arising out of our latest analysis of macro trends and economic data and our innovative Quant work. We also look at upcoming events and suggest topping up on some of our Best Ideas for 2017.